1824 studies found for:    (uterine OR endometrial) AND cancer
Show Display Options
Rank Status Study
21 Unknown  Study of Genes and the Environment in Patients With Endometrial Cancer in the East Anglia, Oxford, Trent, or West Midlands Regions of the United Kingdom
Condition: Endometrial Cancer
Interventions: Genetic: polymorphism analysis;   Other: laboratory biomarker analysis;   Other: questionnaire administration
22 Recruiting Standard Versus Intensity-Modulated Pelvic Radiation Therapy in Treating Patients With Endometrial or Cervical Cancer
Conditions: Cervical Cancer;   Endometrial Cancer;   Gastrointestinal Complications;   Perioperative/Postoperative Complications;   Radiation Toxicity;   Urinary Complications;   Urinary Tract Toxicity
Interventions: Radiation: 3-dimensional conformal radiation therapy;   Radiation: intensity-modulated radiation therapy
23 Unknown  Prophylactic Irradiation of the Para-Aortic Lymph Nodes and Supraclavicular Lymph Nodes in Locally Advanced Uterine Cervical Cancer
Condition: Cervical Cancer
Intervention: Radiation: Prophylactic Irradiation of the Para-Aortic Lymph Nodes and supraclavicular lymph nodes in Locally Advanced Uterine Cervical Cancer
24 Completed A Phase 2 Study of Oral MKC-1 in Patients With Ovarian or Endometrial Cancer
Conditions: Ovarian Cancer;   Endometrial Cancer
Intervention: Drug: MKC-1
25 Recruiting Psychosexual Intervention in Patients With Stage I-III Gynecologic or Breast Cancer
Conditions: Ovarian Sarcoma;   Ovarian Stromal Cancer;   Stage I Uterine Sarcoma;   Stage I Vaginal Cancer;   Stage I Vulvar Cancer;   Stage IA Cervical Cancer;   Stage IA Endometrial Carcinoma;   Stage IA Fallopian Tube Cancer;   Stage IA Ovarian Epithelial Cancer;   Stage IA Ovarian Germ Cell Tumor;   Stage IA Primary Peritoneal Cavity Cancer;   Stage IB Cervical Cancer;   Stage IB Endometrial Carcinoma;   Stage IB Fallopian Tube Cancer;   Stage IB Ovarian Epithelial Cancer;   Stage IB Ovarian Germ Cell Tumor;   Stage IB Primary Peritoneal Cavity Cancer;   Stage IC Fallopian Tube Cancer;   Stage IC Ovarian Epithelial Cancer;   Stage IC Ovarian Germ Cell Tumor;   Stage IC Primary Peritoneal Cavity Cancer;   Stage II Endometrial Carcinoma;   Stage II Gestational Trophoblastic Tumor;   Stage II Uterine Sarcoma;   Stage II Vaginal Cancer;   Stage II Vulvar Cancer;   Stage IIA Cervical Cancer;   Stage IIA Fallopian Tube Cancer;   Stage IIA Ovarian Epithelial Cancer;   Stage IIA Ovarian Germ Cell Tumor;   Stage IIA Primary Peritoneal Cavity Cancer;   Stage IIB Cervical Cancer;   Stage IIB Fallopian Tube Cancer;   Stage IIB Ovarian Epithelial Cancer;   Stage IIB Ovarian Germ Cell Tumor;   Stage IIB Primary Peritoneal Cavity Cancer;   Stage IIC Fallopian Tube Cancer;   Stage IIC Ovarian Epithelial Cancer;   Stage IIC Ovarian Germ Cell Tumor;   Stage IIC Primary Peritoneal Cavity Cancer;   Stage III Gestational Trophoblastic Tumor;   Stage III Uterine Sarcoma;   Stage III Vaginal Cancer;   Stage III Vulvar Cancer;   Stage IIIA Cervical Cancer;   Stage IIIA Endometrial Carcinoma;   Stage IIIA Fallopian Tube Cancer;   Stage IIIA Ovarian Epithelial Cancer;   Stage IIIA Ovarian Germ Cell Tumor;   Stage IIIA Primary Peritoneal Cavity Cancer;   Stage IIIB Cervical Cancer;   Stage IIIB Endometrial Carcinoma;   Stage IIIB Fallopian Tube Cancer;   Stage IIIB Ovarian Epithelial Cancer;   Stage IIIB Ovarian Germ Cell Tumor;   Stage IIIB Primary Peritoneal Cavity Cancer;   Stage IIIC Endometrial Carcinoma;   Stage IIIC Fallopian Tube Cancer;   Stage IIIC Ovarian Epithelial Cancer;   Stage IIIC Ovarian Germ Cell Tumor;   Stage IIIC Primary Peritoneal Cavity Cancer;   Breast Cancer
Intervention: Other: behavioral, psychological or informational intervention
26 Not yet recruiting Biomarkers in Samples From Patients With Endometrial Cancer
Conditions: Lynch Syndrome;   Recurrent Uterine Corpus Carcinoma;   Stage I Uterine Corpus Cancer;   Stage II Uterine Corpus Cancer;   Stage III Uterine Corpus Cancer;   Stage IV Uterine Corpus Cancer
Intervention: Other: Laboratory Biomarker Analysis
27 Active, not recruiting
Has Results
Fludeoxyglucose F 18 PET Scan, CT Scan, and Ferumoxtran-10 MRI Scan Before Chemotherapy and Radiation Therapy in Finding Lymph Node Metastasis in Patients With Locally Advanced Cervical Cancer or High-Risk Endometrial Cancer
Conditions: Cervical Adenocarcinoma;   Cervical Adenosquamous Cell Carcinoma;   Cervical Small Cell Carcinoma;   Cervical Squamous Cell Carcinoma;   Endometrial Clear Cell Carcinoma;   Endometrial Papillary Serous Carcinoma;   Stage I Endometrial Carcinoma;   Stage IB Cervical Cancer;   Stage II Endometrial Carcinoma;   Stage IIA Cervical Cancer;   Stage IIB Cervical Cancer;   Stage III Cervical Cancer;   Stage III Endometrial Carcinoma;   Stage IVA Cervical Cancer
Interventions: Radiation: fludeoxyglucose F 18;   Procedure: positron emission tomography;   Procedure: computed tomography;   Drug: ferumoxtran-10;   Procedure: magnetic resonance imaging;   Procedure: diagnostic lymphadenectomy;   Procedure: lymph node biopsy
28 Completed
Has Results
The Study of Oral Steroid Sulphatase Inhibitor BN83495 Versus Megestrol Acetate (MA) in Women With Advanced or Recurrent Endometrial Cancer
Condition: Endometrial Cancer
Interventions: Drug: BN83495;   Drug: Megestrol Acetate (MA)
29 Terminated Amifostine in Treating Women With Ovarian, Peritoneal, Cervical, Fallopian Tube, Uterine, or Endometrial Cancer
Conditions: Cervical Cancer;   Endometrial Cancer;   Fallopian Tube Cancer;   Neurotoxicity;   Ovarian Cancer;   Primary Peritoneal Cavity Cancer;   Sarcoma
Interventions: Drug: amifostine trihydrate;   Drug: cisplatin;   Drug: paclitaxel
30 Completed Studies of the Tumour Suppressor Gene PTEN - Endometrial Cancer
Condition: Endometrial Neoplasms
Interventions: Behavioral: questionnaire;   Procedure: Blood sample-DNA testing / Tumour-genetic markers
31 Recruiting Follow-up of Endometrial Cancer Patients
Condition: Endometrial Cancer
Intervention: Other: Instruction in self-referral
32 Completed
Has Results
Carboplatin, Docetaxel, and Radiation Therapy in Treating Patients With Stage III/IV, or Recurrent Endometrial Cancer
Condition: Endometrial Cancer
Interventions: Drug: carboplatin;   Drug: docetaxel;   Radiation: radiation therapy
33 Recruiting Irreversible Electroporation(IRE) For Uterine Cervical Neoplasms
Condition: Uterine Cervical Neoplasms
Interventions: Procedure: Irreversible electroporation (IRE);   Device: NanoKnife
34 Active, not recruiting Telephone Follow-up After Treatment for Endometrial Cancer
Condition: Endometrial Cancer
Intervention: Other: Telephone Follow-up
35 Recruiting The Molecular Predisposition to Hereditary Nonpolyposis Colon Cancer (HNPCC)
Conditions: Bladder Cancer;   Colorectal Cancer;   Endometrial Cancer;   Kidney Cancer;   Skin Cancer;   Uterus Cancer
Intervention: Behavioral: Health and Diet Questionnaire
36 Active, not recruiting Investigating the Use of Fluorescence Imaging in Endometrial Cancer Surgery
Condition: Endometrial Cancer
Intervention: Procedure: Fluorescence-guided sentinel lymph node detection
37 Active, not recruiting Diet and Physical Activity in Uterine Cancer Survivors
Condition: Endometrial Neoplasms
Intervention: Behavioral: Shape-Up following cancer treatment
38 Active, not recruiting Pelvic Fractures and Radiation Therapy for Cervical Cancer
Conditions: Cervical Cancer;   Endometrial Cancer;   Vaginal Cancer
Intervention: Procedure: CT or MRI + Blood Test
39 Unknown  Epidemiology of Uterine Cancer in Taiwan
Condition: Uterine Cancers
Intervention: Other: Histologic types
40 Recruiting TREC Lifestyle Beyond Cancer Study in Endometrial Cancer Survivors
Condition: Endometrial Cancer
Interventions: Behavioral: Telemedicine Weight Management plus Wi-Fi Scale (Arm A);   Behavioral: Text for Diet (Text4Diet) Group (Arm B);   Behavioral: Enhanced Usual Care Group (Arm C)

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years